Cita APA (7a ed.)

F, J., H, Z., F, S., L, K., & J, Y. (2016). A retrospective analysis of safety and efficacy of weekly nab-paclitaxel as second-line chemotherapy in elderly patients with advanced squamous non-small-cell lung carcinoma. Dove Medical Press.

Cita Chicago Style (17a ed.)

F, Jin, Zhu H, Shi F, Kong L, y Yu J. A Retrospective Analysis of Safety and Efficacy of Weekly Nab-paclitaxel as Second-line Chemotherapy in Elderly Patients with Advanced Squamous Non-small-cell Lung Carcinoma. Dove Medical Press, 2016.

Cita MLA (8a ed.)

F, Jin, et al. A Retrospective Analysis of Safety and Efficacy of Weekly Nab-paclitaxel as Second-line Chemotherapy in Elderly Patients with Advanced Squamous Non-small-cell Lung Carcinoma. Dove Medical Press, 2016.